• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Edmund Pezalla, MD, MPH, Analyzes the Future of Medicare Advantage Plans

Article

Edmund J. Pezalla, MD, MPH, national medical director, Aetna Pharmacy Management, suggest that the healthcare industry will continue to move in the direction of providing patients incentives to make use of health risk assessment tools and screenings.

Edmund J. Pezalla, MD, MPH, national medical director, Aetna Pharmacy Management, suggest that the healthcare industry will continue to move in the direction of providing patients incentives to make use of health risk assessment tools and screenings. He says many of his organization’s programs have already been actively reducing or eliminating copays for preventive services as well as for certain sorts of critical medications.

“Benefit designs need to support delivery system reform by encouraging the right sorts of behaviors by both the consumers as well as the providers,” Dr Pezalla stated.

Related Videos
Ravi Vij, MD, MBA – AJMC
Dr James Chalmers
Anasuya Gunturi, MD, PhD, Lowell General Hospital
Frank Weinberg, MD, PhD
Dr James Chalmers
Ravi Vij, MD, MBA - AJMC
The 2025 ASPC Congress on CVD Prevention
Dr James Chalmers
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.